Affordable Access

Publisher Website

RAPID AND SAFE TERMINATION OF SUPRAVENTRICULAR TACHYCARDIA IN CHILDREN BY ADENOSINE

Authors
Journal
The Lancet
0140-6736
Publisher
Elsevier
Publication Date
Volume
329
Issue
8528
Identifiers
DOI: 10.1016/s0140-6736(87)92027-7

Abstract

Abstract Adenosine (0·05-0·25 mg/kg intravenously) successfully terminated resistant supraventricular tachycardia (SVT) in three seriously ill newborn infants and one older child. Termination of tachycardia was achieved in each case within 20 s. Adenosine, unlike many other anti-arrhythmic agents, has no substantial negative inotropic effect under these circumstances and may become the drug of choice in haemodynamically compromised children with SVT. However, it has no value in prophylaxis against recurrent SVT.

There are no comments yet on this publication. Be the first to share your thoughts.